Some advocate for the use of the primary tumor, but intertumoral heterogeneity of BRAF between a patient’s primary and subsequent metastatic lesion is still discussed [44,45], and a metanalysis has proposed a possible discrepancy rate of approximately 10% [46]. Here, BRAF is linked to neoplasm.